Adequan Canine Injectable

Adequan Canine (polysulfated glycosaminoglycan) is the only FDA-approved disease-modifying osteoarthritis drug (DMOAD) that inhibits cartilage loss and helps restore joint lubrication. Administered as an intramuscular injection, it targets the disease process at the cellular level rather than just masking pain.